scorecardresearch
Saturday, August 30, 2025
TopicCovaxin

Topic: Covaxin

Covaxin neutralises double mutant Covid strain, says ICMR

The apex health research body said the National Institute of Virology has also demonstrated the neutralisation potential of Covaxin against the UK and Brazil variants.

Bharat Biotech scales up Covaxin manufacturing capacity to 700 million doses a year

The company had 200 million doses capacity when it started producing Covaxin in the beginning, say sources.

Covaxin production to increase 10 times by September, says Harsh Vardhan

Union Health Minister Harsh Vardhan also said that the manufacture of remdesivir jabs, an anti-viral drug against Covid, will be doubled to 74.1 lakh per month by May.

Russia’s Sputnik V vaccine with over 91% efficacy recommended for emergency use in India

If Modi government accepts Central Drugs and Standards Control Organisation's recommendation, Sputnik V will be the third vaccine to be used in India.

More Indians now willing to take vaccine after cases spike, Modi & ministers take shot: Survey

Survey by LocalCircles covering over 27,000 respondents says that 77% Indians are now open to being vaccinated as opposed to 38% in January.

Bharat Biotech’s Covaxin production could go up 7 times with help from Karnataka, Gujarat labs

Plan to increase Covaxin production being overseen by 6-member inter-ministerial panel appointed to augment vaccine manufacturing as Covid cases see a second wave in India.

India orders 12 crore more doses of Covishield, Covaxin at cheaper price tag of Rs 150/shot

Currently, these vaccines cost Rs 210 per dose with taxes. The additional order could lead to the domestic vaccine market opening up.

Bharat Biotech data on 43 Covid cases convinced govt to drop Covaxin from clinical trial mode

Decision to allow Covaxin to exit the clinical trial mode means the vaccine can be administered with less stringent conditions and could result in a higher intake.

Expert panel recommends Covaxin for emergency use, moves out of ‘clinical trial mode’

The recommendations were made after analysis of interim data of the phase-3 clinical trial of Bharat Biotech's Covaxin's showed the efficacy of the vaccine to be 80.6%.

Scientists oppose placebo trials for Covid vaccines, call them ‘unethical, inappropriate’

An expert group of WHO may have advocated for the continued use of blinded placebo-controlled studies for ‘reliable evidence’, but scientific community thinks otherwise. 

On Camera

Mohan Bhagwat’s U-turn on ‘retire at 75’ is a Hindu succession problem

RSS chief Mohan Bhagwat has backtracked on his retirement rules. The ‘75-year rule’ was applied selectively to sideline some leaders, but it doesn’t apply to the top brass.

Easy loans, uneasy ‘debt traps’. Women harassed by private lenders ask ‘who will restore lost dignity?’

A public meeting, where the women voiced their protest, took place this month in Delhi, grounded on the findings of an AIDWA survey, covering 9,000 women borrowers.

Ahead of SCO meet, Russia & China stage maiden joint submarine patrol in Sea of Japan, East China Sea

Joint submarine patrol ‘covered more than 2,000 nautical miles’ and was joined by Russian support vessels. Beijing maintains exercise ‘not directed against any third party’.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.